2seventy bio, Inc.
TSVT
NASDAQ
Corporate Info
617 675 7270
60 Binney Street
Cambridge, MA 02142
Cambridge, MA 02142
United States
2021
Details
Health Care
Pharmaceuticals, Biotechnology and Life Sciences
274
Business Decription
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company’s products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.